Empagliflozin: a wonder drug for the treatment of SIAD?

The article discusses the potential of empagliflozin, a drug used for type 2 diabetes, as a treatment for the syndrome of inappropriate antidiuresis (SIAD). Empagliflozin works by inducing glycosuria, leading to increased renal electrolyte-free water excretion. Studies have shown that empagliflozin can increase serum sodium levels in patients with SIAD, making it a promising treatment option. However, further research is needed to fully understand its efficacy and safety in different patient populations. [Extracted from the article]